Dr. Sabine Hazan, CEO of Progenabiome, studied the microbiomes of COVID-19 patients and discovered that severe cases lacked bifidobacteria.
She developed treatment protocols to increase gut bacteria, and discusses the impact of COVID-19 vaccines on the microbiome. Watch this episode and learn more from her expert advice on gut health and COVID-19.